Opening Lecture "Stem cell renewal and the matrix"
P. Noble (Los Angeles, USA)
|   |
A phenotypic high-throughput screening assay for the pharmacological inhibition of the pathological deposition of extracellular matrix
G. Burgstaller (Munich, Germany)
| |
Matrix abnormalities in pulmonary fibrosis
M. Kolb (Hamilton, Canada)
| |
Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
M. Nikolic (Cambridge, United Kingdom)
| |
Time-resolved proteomic characterization of ECM remodelling in human lung scaffold cultures using stable isotope labelling
O. Rosmark (Lund, Sweden)
| |
The activation of MET-driven invasive growth in IPF and metastasis is modulated by different mechanisms of cell/matrix interaction
G. M. Stella (Pavia, Italy)
| |
Matrix/pathogen interactions
K. Riesbeck (Malmö, Sweden)
| |
Guidance cues in the pulmonary environment propel in vivo dynamic movement of group 2 innate lymphoid cells after inflammation
F. Puttur (London, United Kingdom)
| |
Matrikines in lung inflammation
R. Snelgrove (London, United Kingdom)
| |
FKBP10 regulates fibroblast migration via synthesis of collagen VI
L. Knüppel (Munich, Germany)
| |
Specialized fibroblasts in wound healing
Y. Rinkevich (Munich, Germany)
| |
Poster Session 1
S. Rønnow (Herlev, Denmark); I. Janulaityte (Kaunas, Lithuania) A. Goodwin (Nottingham, United Kingdom); K. Arendt (Munich, Germany); H. Zuo (Groningen, Netherlands); E. Tsitoura (Heraklion, Greece); C-A. Brandsma (Groningen, Netherlands); R. T. Martinez-Nunez (London, United Kingdom) M. Oplopoiou (Rion, Greece); V.Kheirollahi (Giessen, Germany) L. Elowsson (Lund, Sweden); K. Son (Hamilton, Canada); R. Mahida (Birmingham, United Kingdom); M. Lizé (Göttingen, Germany); T. Maes (Ghent, Belgium); H. Sun (New Haven, USA); M. Zysman (Vincennes, France); C. Nanthakumar (Hertfordshire, United Kingdom); K. Fytianos (Bern, Switzerland); O. Hallgren (Lund, Sweden); L. Wanat (Munich, Germany); O. Brand (Manchester, United Kingdom); J. W. Duitman (Paris, France); K. Ivanova (Stara Zagora, Bulgaria); M. Redding (Bedfordshire, United Kingdom); I. Almendros (Barcelona, Spain); D. J. Hof (Nijmegen, Netherlands); M. Szczygiel (Heidelberg, Germany); K. Stephenson (Nottingham, United Kingdom); X. Zhou (Molndal, Sweden); R. Schliep (Hannover, Germany); I. Giopanou (Rio, Greece); S. van Riet (Leiden, Netherlands); S. Casas (Barcelona, Spain); C. Sepult (Liège, Belgium); I. Mahmutovic Persson (Lund, Sweden); C. E. Machahua (Barcelona, Spain); B. Pilecki (Odense, Denmark); S. Lui (Manchester, United Kingdom)
| |
Mechanosensing – converting tension into chemical signals
B. Wehrle-Haller (Geneva, Switzerland)
| |
Mechanical programming of mesenchymal stromal cells to treat lung fibrosis
J-W. Shin (Chicago, USA)
| |
When is an alveolar epithelial cell an alveolar epithelial cell?
M. Beers (Wayne, USA)
| |
MTOR regulates TGFß-induced collagen synthesis via increased glycine biosynthesis
A. Ilan (Canada)
| |
Impaired angiogenic supportive capacity and altered gene expression profile of CD146 mesenchymal stromal cells isolated from hyperoxia-injured neonatal rat lungs
J. J.P.Collins (Rotterdam, Netherlands)
| |
PRRX1 a pro-fibrotic mesenchymal transcription factor modulated by remodeled microenvironment in IPF
E. Marchal-Duval (Paris, France)
| |
Laser-capture microdissection, mass spectrometry and immunohistochemistry reveal pathologic alterations in the extracellular matrix of transplanted lungs
C. Mueller (Lund, Sweden)
| |
Bronchial fibrocyte-like cells accumulate in chronic obstructive pulmonary disease (COPD) lungs.
I. Dupin (Bordeaux, France)
| |
Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension
S. Collum (Houston, USA)
| |
Poster Session 2
J. Mills (Sheffield, United Kingdom); S. Rønnow (Herlev, Denmark); A. Tzouvelekis (Athens, Greece); S. Bartel (Borstel, Germany); J. G. Pichel (Logroño, Spain); P. Ogger (London, United Kingdom); H. N. Alsafadi (Lund, Sweden); A-S. Lamort (Munich, Germany); K. Bracke (Ghent, Belgium); D. Kruk (Groningen, Netherlands); K. Krempaska (Bern, Switzerland); N. Parmar (London, United Kingdom); G. Ntaliarda (Rio, Greece); H. Schlüter (Mölndal, Sweden); J. Raudoniute (Vilnius, Lithuania); J. Alcaraz Casademunt (Barcelona, Spain); S. van Riet (Leiden, Netherlands); C. Upagupta (Hamilton, Canada); E. Papakonstantinou (Thessaloniki, Greece); H. Woodcock (London, United Kingdom); I. Cattani-Cavalieri (Groningen, Netherlands);L. H. Andrade da Silva (Rio de Janeiro, Brazil); S. Sato (Hamilton, Canada); A. Konishcheva (Moscow, Russian Federation); D. Cm Simoes (Athens, Greece); G. Giotopoulou (Patra, Greece); M. Kadefors (Malmö, Sweden); T. Karampitsakos (Thebes, Greece); E. Letsiou (Berlin, Germany); P. Duch Gili (Barcelona, Spain); J. Cairns (Nottingham, United Kingdom); F. Uhl, (Burlington, USA); A. Januskevicius (Kaunas, Lithuania); M. De Santis (Lund, Sweden); N. Gudmann (Herlev, Denmark); T. C. J. Mertens (Houston, USA); P. Oak (Munich, Germany); D. Ali Bölükbas (Lund, Sweden)
| |
Visualization of cell-matrix interactions during immune cell interactions and tumour invasion
P. Friedl (Nijmegen, Netherlands)
| |
Late-breaking abstracts Session
A.C. Ucero (Madrid, Spain); I. Angelidis (Munich, Germany); D. Guillotin (London, United Kingdom)
| |
Lung Bioprinting - opportunities and challenges
R. Farré Ventura (Barcelona, Spain)
| |